Turning Point Brands surges on earnings beat, Modern Oral growth
Nicotine pouch segment sales jump 266%, now account for one-third of revenue as CEO targets double-digit market share
Turning Point Brands shares rallied in Tuesday trading after the tobacco products company delivered fourth-quarter adjusted earnings of $0.95 per share, significantly surpassing analyst expectations. The Louisville-based company reported revenue of $121.0 million for the quarter, a 29.2% increase from the prior year and beating analyst forecasts.
The standout performance came from the company's Modern Oral segment, which includes the FRE and ALP nicotine pouch brands. Sales in the category surged 266% year-over-year to reach $41.3 million, now representing 34% of total net sales compared with just 12% in the fourth quarter of 2024, according to company results announced March 2.
Chief Executive Officer Graham Purdy highlighted the strength of the FRE and ALP brands in driving growth. "We are excited by the growth of the modern oral category and the strong performance of our FRE and ALP brands," Purdy said, according to the earnings announcement. He added that the company is "well positioned to achieve double-digit share of the category over time, while our legacy brands continue to generate durable cash flows that provide strong funding for investment in future growth."
The company raised its fiscal year 2026 guidance for the Modern Oral segment, projecting gross revenue of $220 million to $240 million and net revenue of $180 million to $190 million. The updated outlook reflects management's confidence in the nicotine pouch market, which Turning Point Brands believes will ultimately feature five to six dominant brands competing for shelf space.
Analysts have taken notice of the momentum. Oppenheimer raised its price target on the stock to $130 from $120 in mid-January, maintaining an "Outperform" rating. The company's current analyst consensus price target stands at $121.25, with four buy ratings and one hold among covering analysts, according to market data.
The strong earnings performance comes amid a broader shift in the tobacco industry toward reduced-risk products. Traditional combustible cigarettes face declining consumption rates and increasing regulatory pressure, while modern oral nicotine products have emerged as a high-growth category. Turning Point Brands, which also produces loose leaf tobacco, roll-your-own products, and pipe tobacco, is positioning its modern oral segment as a key growth engine.
The stock has been on an upward trajectory, gaining approximately 17% over the past month and trading near its 52-week high of $146.90 reached earlier this year. Despite the recent rally, shares remain well below their March peak, offering potential upside for investors who believe in the company's transition strategy. Institutional investors hold 97.3% of outstanding shares, indicating strong institutional confidence in the turnaround story.
Turning Point Brands' net income increased 240% year-over-year in the quarter, though the company did not disclose the absolute dollar amount in its preliminary announcement. The profit margin expansion reflects both the rapid growth of higher-margin modern oral products and operational efficiency improvements across the business.
Looking ahead, investors will be watching for retail distribution expansion of the ALP brand, which was initially planned as a direct-to-consumer exclusive but has already begun appearing in select brick-and-mortar retail tests ahead of schedule. The company's ability to secure shelf space in convenience stores and other traditional tobacco retail channels will be critical to achieving its market share targets.
The company's legacy tobacco operations continue to generate substantial cash flow that management is reinvesting in the modern oral business. This strategy of using established revenue streams to fund growth initiatives in emerging categories has become increasingly common in the tobacco sector, as companies navigate the complex transition away from combustible products.